Dong OM, Friede KA, Chanfreau-Coffinier C, Voora D. One-year cost-effectiveness of CYP2C19-guided P2Y12 inhibitor de-escalation and escalation in veterans undergoing percutaneous coronary intervention. Presented at the Virtual NHGRI Research Training and Career Development Annual Meeting; April 19, 2021.